News2022-09-12T16:29:50-05:00
January 17th, 2025|

DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against Walgreens

Walgreens allegedly failed in its duties under the Controlled Substances Act by filling medically unnecessary prescriptions and ignoring red flags. Washington, D.C. -- Yesterday, the United States Department of Justice (DOJ) filed a complaint in intervention in four separate whistleblower lawsuits brought by whistleblowers under the Controlled Substances Act (CSA) [...]

Baron & Budd Whistleblower Cases Highlighted in 2019 Department of Justice Year End Press Release

January 31st, 2020|

The United States Department of Justice (DOJ) recently released an end of year statement announcing the success of its efforts in combating fraud against the [...]

Baron & Budd Announces $20,225,000 Million Settlements in Whistleblower Case Alleging Small Business Fraud by Atlantic Diving Supply Executives

August 20th, 2019|

Collective settlements against ADS and its executives resulted in nearly $37 million in settlements – the largest settlement ever secured in a small business fraud [...]

Baron & Budd Announces $1.4 Billion Settlement Against Opioid Manufacturer Reckitt Benckiser Group plc

July 11th, 2019|

Agreement represents largest settlement ever secured against an opioid manufacturer July 11, 2019 WASHINGTON--Today, the national law firm of Baron & Budd announced that a False Claims [...]

Go to Top